[1]
“ADVERSE PREGNANCY OUTCOMES AND MID/ TRIMESTER UTERINE ARTERY DOPPLER IN HIGH-RISK PREGNANCIES”, Int. Res. J. Pharm., vol. 13, no. 8, pp. 48–52, Aug. 2022, doi: 10.56802/dcbsv314.